Skip to main content
OpenTrials

Clinical trial condition

Advanced Breast Cancer

Explore clinical trials studying Advanced Breast Cancer. Study availability and eligibility vary by location and protocol.

175 public trials 63 recruiting studies
Refine in advanced search Browse all conditions

Advanced Breast Cancer trial results

Recruiting

A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer

NCT07227831

Conditions
Advanced Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations
  • Karmanos Cancer Institute at McLaren Bay Region Bay City, Michigan, United States
  • Karmanos Cancer Institute at McLaren Clarkston Clarkston, Michigan, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Karmanos Cancer Institute at McLaren Flint Flint, Michigan, United States
View Trial Details
Recruiting

Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.

NCT06382948

Conditions
Advanced Breast Cancer, ER-positive Breast Cancer, ESR1 Gene Mutation, +1 more
Locations
  • Medizinische Universität Innsbruck Innsbruck, Austria
  • Ordensklinikum Linz Barmherzige Schwestern Linz, Austria
  • Ordination Priv.-Doz. Dr. Michael Hubalek Schwaz, Austria
  • Medical University of Vienna Vienna, Austria
View all 104 locations
View Trial Details
Recruiting

Decision Support Tool for Patients With Advanced Breast Cancer

NCT07635147

Conditions
Advanced Breast Cancer, Behavior, Breast Cancer Metastatic, +13 more
Locations
  • NewYork-Presbyterian Brooklyn Methodist Hospital Brooklyn, New York, United States
  • NewYork-Presbyterian David H. Koch Center New York, United States
  • NewYork-Presbyterian Medical Group Queens Flushing, New York, United States
View Trial Details
Recruiting

Phase III Study to Evaluate the Safety, Efficacy, and Impact on Quality of Life of Capivasertib Alongside Standard-of-care Endocrine Treatment in Patients With HR+/HER2- Advanced Breast Cancer and Progression on Prior Endocrine-based Treatment

NCT07281833

Conditions
Advanced Breast Cancer, Breast Cancer, Breast Diseases, +14 more
Locations
  • Institut Jules Bordet Anderlecht, Belgium
  • St. Elisabeth-Krankenhaus GmbH, Brustzentrum - Senologie Cologne, North Rhine-Westphalia, Germany
  • Universitätsklinikum Essen Essen, North Rhine-Westphalia, Germany
  • Brustzentrum Niederrhein, Johanniter Bethesda Krankenhaus Mönchengladbach, North Rhine-Westphalia, Germany
View all 16 locations
View Trial Details
Recruiting

Safety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal Subtype

NCT06486883

Conditions
Advanced Breast Cancer, Advanced Breast Carcinoma, Hormone Receptor Positive Breast Carcinoma
Locations
  • Kepler Universitäts Klinikum Linz, Austria
  • Medical University of Vienna Vienna, Austria
  • Algemeen Ziekenhuis Klina Brasschaat, Belgium
  • Ghent University Hospital Ghent, Belgium
View all 79 locations
View Trial Details

Related conditions